Sprouty2 is involved in the control of osteoblast proliferation and differentiation through the FGF and BMP signaling pathways

Takaharu Taketomi, Tomohiro Onimura, Daigo Yoshiga, Daichi Muratsu, Terukazu Sanui, Takao Fukuda, Jingo Kusukawa, Seiji Nakamura

Research output: Contribution to journalArticle

Abstract

Fibroblast growth factor (FGF) and bone morphogenetic protein (BMP) play essential roles in bone formation and osteoblast activity through the extracellular signal-regulated kinase 1/2 (ERK1/2) and Smad pathways. Sprouty family members are intracellular inhibitors of the FGF signaling pathway, and four orthologs of Sprouty have been identified in mammals. In vivo analyses have revealed that Sprouty2 is associated with bone formation. However, the mechanism by which the Sprouty family controls bone formation has not been clarified. In this study, we investigated the involvement of Sprouty2 in osteoblast proliferation and differentiation. We examined Sprouty2 expression in MC3T3-E1 cells, and found that high levels of Sprouty2 expression were induced by basic FGF stimulation. Overexpression of Sprouty2 in MC3T3-E1 cells resulted in suppressed proliferation compared with control cells. Sprouty2 negatively regulated the phosphorylation of ERK1/2 after basic FGF stimulation, and of Smad1/5/8 after BMP stimulation. Furthermore, Sprouty2 suppressed the expression of osterix, alkaline phosphatase, and osteocalcin mRNA, which are markers of osteoblast differentiation. Additionally, Sprouty2 inhibited osteoblast matrix mineralization. These results suggest that Sprouty2 is involved in the control of osteoblast proliferation and differentiation by downregulating the FGF-ERK1/2 and BMP-Smad pathways, and suppresses the induction of markers of osteoblast differentiation.

Original languageEnglish
Pages (from-to)1106-1114
Number of pages9
JournalCell Biology International
Volume42
Issue number9
DOIs
Publication statusPublished - Sep 1 2018

Fingerprint

Bone Morphogenetic Proteins
Fibroblast Growth Factors
Osteoblasts
Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinase 1
Osteogenesis
Differentiation Antigens
Fibroblast Growth Factor 2
Osteocalcin
Alkaline Phosphatase
Mammals
Down-Regulation
Phosphorylation
Messenger RNA

All Science Journal Classification (ASJC) codes

  • Cell Biology

Cite this

Sprouty2 is involved in the control of osteoblast proliferation and differentiation through the FGF and BMP signaling pathways. / Taketomi, Takaharu; Onimura, Tomohiro; Yoshiga, Daigo; Muratsu, Daichi; Sanui, Terukazu; Fukuda, Takao; Kusukawa, Jingo; Nakamura, Seiji.

In: Cell Biology International, Vol. 42, No. 9, 01.09.2018, p. 1106-1114.

Research output: Contribution to journalArticle

Taketomi, Takaharu ; Onimura, Tomohiro ; Yoshiga, Daigo ; Muratsu, Daichi ; Sanui, Terukazu ; Fukuda, Takao ; Kusukawa, Jingo ; Nakamura, Seiji. / Sprouty2 is involved in the control of osteoblast proliferation and differentiation through the FGF and BMP signaling pathways. In: Cell Biology International. 2018 ; Vol. 42, No. 9. pp. 1106-1114.
@article{9a3a1ae8832a4890aab748188cbaf22c,
title = "Sprouty2 is involved in the control of osteoblast proliferation and differentiation through the FGF and BMP signaling pathways",
abstract = "Fibroblast growth factor (FGF) and bone morphogenetic protein (BMP) play essential roles in bone formation and osteoblast activity through the extracellular signal-regulated kinase 1/2 (ERK1/2) and Smad pathways. Sprouty family members are intracellular inhibitors of the FGF signaling pathway, and four orthologs of Sprouty have been identified in mammals. In vivo analyses have revealed that Sprouty2 is associated with bone formation. However, the mechanism by which the Sprouty family controls bone formation has not been clarified. In this study, we investigated the involvement of Sprouty2 in osteoblast proliferation and differentiation. We examined Sprouty2 expression in MC3T3-E1 cells, and found that high levels of Sprouty2 expression were induced by basic FGF stimulation. Overexpression of Sprouty2 in MC3T3-E1 cells resulted in suppressed proliferation compared with control cells. Sprouty2 negatively regulated the phosphorylation of ERK1/2 after basic FGF stimulation, and of Smad1/5/8 after BMP stimulation. Furthermore, Sprouty2 suppressed the expression of osterix, alkaline phosphatase, and osteocalcin mRNA, which are markers of osteoblast differentiation. Additionally, Sprouty2 inhibited osteoblast matrix mineralization. These results suggest that Sprouty2 is involved in the control of osteoblast proliferation and differentiation by downregulating the FGF-ERK1/2 and BMP-Smad pathways, and suppresses the induction of markers of osteoblast differentiation.",
author = "Takaharu Taketomi and Tomohiro Onimura and Daigo Yoshiga and Daichi Muratsu and Terukazu Sanui and Takao Fukuda and Jingo Kusukawa and Seiji Nakamura",
year = "2018",
month = "9",
day = "1",
doi = "10.1002/cbin.10876",
language = "English",
volume = "42",
pages = "1106--1114",
journal = "Cell Biology International",
issn = "1065-6995",
publisher = "Portland Press Ltd.",
number = "9",

}

TY - JOUR

T1 - Sprouty2 is involved in the control of osteoblast proliferation and differentiation through the FGF and BMP signaling pathways

AU - Taketomi, Takaharu

AU - Onimura, Tomohiro

AU - Yoshiga, Daigo

AU - Muratsu, Daichi

AU - Sanui, Terukazu

AU - Fukuda, Takao

AU - Kusukawa, Jingo

AU - Nakamura, Seiji

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Fibroblast growth factor (FGF) and bone morphogenetic protein (BMP) play essential roles in bone formation and osteoblast activity through the extracellular signal-regulated kinase 1/2 (ERK1/2) and Smad pathways. Sprouty family members are intracellular inhibitors of the FGF signaling pathway, and four orthologs of Sprouty have been identified in mammals. In vivo analyses have revealed that Sprouty2 is associated with bone formation. However, the mechanism by which the Sprouty family controls bone formation has not been clarified. In this study, we investigated the involvement of Sprouty2 in osteoblast proliferation and differentiation. We examined Sprouty2 expression in MC3T3-E1 cells, and found that high levels of Sprouty2 expression were induced by basic FGF stimulation. Overexpression of Sprouty2 in MC3T3-E1 cells resulted in suppressed proliferation compared with control cells. Sprouty2 negatively regulated the phosphorylation of ERK1/2 after basic FGF stimulation, and of Smad1/5/8 after BMP stimulation. Furthermore, Sprouty2 suppressed the expression of osterix, alkaline phosphatase, and osteocalcin mRNA, which are markers of osteoblast differentiation. Additionally, Sprouty2 inhibited osteoblast matrix mineralization. These results suggest that Sprouty2 is involved in the control of osteoblast proliferation and differentiation by downregulating the FGF-ERK1/2 and BMP-Smad pathways, and suppresses the induction of markers of osteoblast differentiation.

AB - Fibroblast growth factor (FGF) and bone morphogenetic protein (BMP) play essential roles in bone formation and osteoblast activity through the extracellular signal-regulated kinase 1/2 (ERK1/2) and Smad pathways. Sprouty family members are intracellular inhibitors of the FGF signaling pathway, and four orthologs of Sprouty have been identified in mammals. In vivo analyses have revealed that Sprouty2 is associated with bone formation. However, the mechanism by which the Sprouty family controls bone formation has not been clarified. In this study, we investigated the involvement of Sprouty2 in osteoblast proliferation and differentiation. We examined Sprouty2 expression in MC3T3-E1 cells, and found that high levels of Sprouty2 expression were induced by basic FGF stimulation. Overexpression of Sprouty2 in MC3T3-E1 cells resulted in suppressed proliferation compared with control cells. Sprouty2 negatively regulated the phosphorylation of ERK1/2 after basic FGF stimulation, and of Smad1/5/8 after BMP stimulation. Furthermore, Sprouty2 suppressed the expression of osterix, alkaline phosphatase, and osteocalcin mRNA, which are markers of osteoblast differentiation. Additionally, Sprouty2 inhibited osteoblast matrix mineralization. These results suggest that Sprouty2 is involved in the control of osteoblast proliferation and differentiation by downregulating the FGF-ERK1/2 and BMP-Smad pathways, and suppresses the induction of markers of osteoblast differentiation.

UR - http://www.scopus.com/inward/record.url?scp=85031106261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031106261&partnerID=8YFLogxK

U2 - 10.1002/cbin.10876

DO - 10.1002/cbin.10876

M3 - Article

VL - 42

SP - 1106

EP - 1114

JO - Cell Biology International

JF - Cell Biology International

SN - 1065-6995

IS - 9

ER -